Logo image of CANS.CA

WILDPACK BEVERAGE INC (CANS.CA) Stock Fundamental Analysis

TSX-V:CANS - TSX Venture Exchange - CA96812Y1016 - Common Stock - Currency: CAD

0.005  0 (0%)

Fundamental Rating

2

Overall CANS gets a fundamental rating of 2 out of 10. We evaluated CANS against 12 industry peers in the Beverages industry. Both the profitability and financial health of CANS have multiple concerns. CANS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CANS has reported negative net income.
CANS had a negative operating cash flow in the past year.
CANS.CA Yearly Net Income VS EBIT VS OCF VS FCFCANS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

CANS has a Return On Assets of -81.96%. This is in the lower half of the industry: CANS underperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -81.96%
ROE N/A
ROIC N/A
ROA(3y)-47.31%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CANS.CA Yearly ROA, ROE, ROICCANS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 200 -200 400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CANS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CANS.CA Yearly Profit, Operating, Gross MarginsCANS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -20 -40 -60 -80 -100

More info and screens

1

2. Health

2.1 Basic Checks

CANS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CANS has been reduced compared to 1 year ago.
The debt/assets ratio for CANS is higher compared to a year ago.
CANS.CA Yearly Shares OutstandingCANS.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
CANS.CA Yearly Total Debt VS Total AssetsCANS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -5.19, we must say that CANS is in the distress zone and has some risk of bankruptcy.
CANS has a Altman-Z score (-5.19) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.19
ROIC/WACCN/A
WACC4.32%
CANS.CA Yearly LT Debt VS Equity VS FCFCANS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 10M -10M 20M -20M 30M

2.3 Liquidity

CANS has a Current Ratio of 0.17. This is a bad value and indicates that CANS is not financially healthy enough and could expect problems in meeting its short term obligations.
CANS has a Current ratio of 0.17. This is amonst the worse of the industry: CANS underperforms 83.33% of its industry peers.
CANS has a Quick Ratio of 0.17. This is a bad value and indicates that CANS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CANS (0.13) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.13
CANS.CA Yearly Current Assets VS Current LiabilitesCANS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

CANS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.78%.
CANS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.84%.
The Revenue has been growing by 90.31% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-19.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-208.73%
Revenue 1Y (TTM)4.84%
Revenue growth 3Y90.31%
Revenue growth 5YN/A
Sales Q2Q%9.18%

3.2 Future

The Earnings Per Share is expected to grow by 47.20% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 59.43% on average over the next years. This is a very strong growth
EPS Next Y66.67%
EPS Next 2Y47.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year71.37%
Revenue Next 2Y59.43%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CANS.CA Yearly Revenue VS EstimatesCANS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 50M 100M 150M
CANS.CA Yearly EPS VS EstimatesCANS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 -0.1 -0.2 -0.3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CANS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 0.12 indicates a rather cheap valuation of CANS.
CANS's Price/Forward Earnings ratio is rather cheap when compared to the industry. CANS is cheaper than 100.00% of the companies in the same industry.
CANS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 0.12
CANS.CA Price Earnings VS Forward Price EarningsCANS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CANS.CA Per share dataCANS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

CANS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CANS's earnings are expected to grow with 47.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.2%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CANS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WILDPACK BEVERAGE INC

TSX-V:CANS (3/7/2025, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-27 2024-11-27
Earnings (Next)N/A N/A
Inst Owners5.95%
Inst Owner ChangeN/A
Ins Owners27.88%
Ins Owner ChangeN/A
Market Cap500.90K
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-44.84%
Min Revenue beat(2)-46.9%
Max Revenue beat(2)-42.79%
Revenue beat(4)0
Avg Revenue beat(4)-42.26%
Min Revenue beat(4)-49%
Max Revenue beat(4)-30.35%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.12
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.6
EYN/A
EPS(NY)0.04
Fwd EY868.84%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.79
BVpS-0.8
TBVpS-1.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -81.96%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.31%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.31%
Cap/Sales 0.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.13
Altman-Z -5.19
F-Score3
WACC4.32%
ROIC/WACCN/A
Cap/Depr(3y)43.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.62%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-208.73%
EPS Next Y66.67%
EPS Next 2Y47.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.84%
Revenue growth 3Y90.31%
Revenue growth 5YN/A
Sales Q2Q%9.18%
Revenue Next Year71.37%
Revenue Next 2Y59.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year173.69%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.51%
OCF growth 3YN/A
OCF growth 5YN/A